method searches, such as I want to kill myself. Likewise, social media companies have implemented strategies to reach suicidal users who need help.
Place-Based Inequity in Smoking Prevalence in the Largest Cities in the United States
Achieving universal health and well-being for all Americans is the ideal goal for US public health efforts, but inequities in chronic disease and life expectancy present a persistent challenge, particularly in large cities. 1 In 2016, the Robert Wood Johnson Foundation and the US Centers for Disease Control and Prevention launched the 500 Cities Project, providing small-area estimates of modifiable risk factors for chronic disease in the 500 largest US cities. 2 To guide prevention efforts, we used these data to characterize inequities in cigarette smoking both between and within cities and in relation to sociodemographic factors and chronic diseases.
Methods | The 500 Cities Project provides model-estimated health indicators at the census-tract level from the 2014 Behavioral Risk Factor Surveillance Survey. 2 A census tract is generally smaller than a city, larger than a block group, and a fairly permanent subdivision of a county. Our analysis used the prevalence of adult (≥18 years) self-reported current smoking, asthma, chronic obstructive pulmonary disease (COPD), and coronary heart disease (CHD). Complete data from the 500 Cities Project were available for 27 204 tracts. We combined the 500 Cities Project estimates with tract-level sociodemographic data from the American Community Survey (2012-2016) and counts of likely tobacco retailers from 10 North American Industrial Classification System codes in the National Establishment Time Series Data for 2012 (120 470 tobacco retailers in the 27 204 tracts). 3 We used linear mixed models to characterize smoking prevalence inequities within and between cities; assess tract-level Google News  42 500  25 300  216  22 400  120 000  4940   Twitter  972 500  342 200  258  2 205 300  2 117 000  20 900   Google search  14 700 000  1 200 000  8000  18 900 000  3 827 000  29 000 a Counts reflect weekly volumes for news stories archived on the study sources 1 week after Lovato's overdose (July 24, 2018) and Bourdain's suicide (June 8, 2018).
b Raw Google search volumes were estimated by monitoring queries per 10 million, with the denominator inferred from comScore summaries. Searches for help or helpline were also included to capture those searching for these national hotlines.
c Excludes matching content that also included blast, bomber, doors,orsquad.
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Letters smoking prevalence as a function of tract-level sociodemographic characteristics and tobacco retailer counts; and assess tract-level asthma, COPD, and CHD prevalence as a function of tract-level smoking prevalence. We also computed Gini coefficients to quantify the dispersion of smoking prevalence between census tracts within each of the 500 cities, where 0 = perfect equality and 1 = maximal inequality. 4 Data sources and analytical methods are further detailed in the Supplement.
Results | Smoking prevalence inequities were greater between tracts within cities (56.1% of the total variation) than between cities (43.9% of the total variation) (Table) . Tracts with higher smoking prevalence had more tobacco retailers (5-store increase, β = 0.11; 95% CI, 0.07-0.16; P < .001), lower median household income ($10 000 increase, β = −0.92; 95% CI, −0.94 to −0.90; P < .001), and a smaller percentage of non-Hispanic white residents (10% increase, β = −0.84; 95% CI, −0.86 to −0.82; P < .001).
Although all cities had some smoking prevalence inequity ( . B, The prevalence of current self-reported asthma, chronic obstructive pulmonary disease (COPD), and coronary heart disease (CHD) is higher in tracts with higher prevalence of current smoking.
Estimates shown in Figure 1B result from multivariable linear mixed models that adjust for percent non-Hispanic white population, median household income, total population size, and a random effect for city. We calculated the expected percent increase in prevalence of each chronic disease of changing from the 10th to 90th percentile of smoking prevalence (from 10.7% to 27.6%) and the corresponding 95% confidence intervals using these multivariable linear mixed models and by using 1000 draws from the multivariate normal distribution with the mean equal to the maximum likelihood point estimate and the variance equal to the coefficient covariance matrix. C, Differences in tract-level smoking prevalence for the city with the greatest inequity in smoking prevalence: Washington, DC (Gini = 0.23). The color in the image uses Jenks natural breaks (9 classes) based on the data for the Washington, DC, census tracts. One Washington, DC, census tract had insufficient data to make a smoking prevalence estimate and is illustrated in gray. Data sources and analytical methods are further detailed in the supplementary appendix. At the tract level, higher smoking prevalence was associated with higher prevalence of asthma, COPD, and CHD (Figure, B) . For instance, a change from the 10th to the 90th percentile of smoking prevalence (from 10.7% to 27.6%) was associated with a 38.9% (95% CI, 38.1%-39.5%) increase in the prevalence of asthma, a 120.2% (95% CI, 116.6%-124.0%) increase in the prevalence of COPD, and a 26.6% (95% CI, 24.5%-29.0%) increase in the prevalence of CHD.
Discussion | Smoking prevalence was unevenly distributed both within and between America's largest cities, and was associated with inequities in income, race, exposure to tobacco retailers, and smoking-related diseases. Strengthening existing tobacco control interventions, such as raising excise taxes and implementing cessation programs targeted to resource-poor communities, may aid in counteracting these inequities in smoking. 5 In addition, novel policies that restrict the retail environment (eg, by limiting the quantity, location, and type of tobacco retailers) show promise for reducing the unequal distribution of tobacco retailers and warrant further investigation. 
Utilization of Long-Acting Reversible Contraceptives in the United States After vs Before the 2016 US Presidential Election
Soon after the US presidential election on November 8, 2016, media and industry reports described an increase in utilization of long-acting reversible contraceptive (LARC) methods (intrauterine devices and implants). 1 Proposed reasons included women's concerns about contraceptive access should the Patient Protection and Affordable Care Act (ACA) be repealed during the Trump Administration. These reports, however, were descriptive and did not control for seasonal or secular trends. Using data from a large sample of commercially insured women, we sought to assess whether there was an increase in LARC utilization among commercially insured women during the 30 days after the election, compared with the 30 days before the election and the same period in 2015.
Methods | Using the IBM/Truven MarketScan Analytics Commercial Claims and Encounters Database, we studied women aged 18 to 45 years enrolled in commercial insurance during the 30 business days before and after November 8 in 2015 or 2016 who had at least 12 months of continuous enrollment. We used billing codes (eTable in the Supplement) to calculate daily LARC insertion rates during the 30 business days before (inclusive of November 8) and 30 days after November 8 in 2015 and 2016. To account for secular trends, we estimated changes in daily LARC insertions using a difference-in-differences generalized linear model with a Poisson distribution and log link function that compared the change in probability of LARC insertion during the 30 business days before vs after November 8, 2016, with the change in the comparable period in 2015. With person-day as the unit of analysis, we adjusted for age group, region, relationship to the insured individual, and plan type (Table) and accounted for clustering by individuals (because individuals contributed information for multiple time points). Wald tests were used to calculate the P values. We considered a 2-sided P < .05 to indicate statistical significance. The Harvard Medical School Office of Human Research Administration exempted the study from human subject review; therefore, patient consent was not required. All data were deidentified. Health, Epidemiology and Surveillance Branch. More information about the methodology used to make estimates can be found at: https://www.cdc.gov/500cities/methodology.htm. These data represent a first of its kind effort to release information on a large scale for cities and for small areas within those cities. It includes estimates for the 500 largest US cities and approximately 28,000 census tracts within these cities.
Results |
We used the census tract prevalence estimates of adult (18+ years) self reported current smoking (mean = 18.4%; SD = 6.5%), asthma (mean = 9.5%; SD = 1.7%), chronic obstructive pulmonary disease (mean = 6.2%; SD = 2.5%) and coronary heart disease (mean = 5.6%; SD = 2.1%) for all 27,204 tracts with complete information.
Neighborhood Demographics: American Community Survey
The source for neighborhood demographics in our analysis was the American Community Survey (ACS), an ongoing survey conducted by the US census bureau that provides data on a broad range of topics including social, economic, demographic, and housing characteristics of the U.S. population across multiple geographic areas (https://www.census.gov/data/developers/data sets/acs 5year.html). Using the 5 year (Table S1 ). We further pruned the purchased address list by excluding stores that are known not to sell tobacco, including: ABC stores, Aldi, Trader Joes, Whole Foods, JC Penny, Macy's, Sears, Marshalls, TJ Maxx, Target, KMART, Big Lots, and Dollar
Tree. Finally, we also restricted the pharmacy category to the top 50 pharmacies that sold tobacco in 2012 (Table S2 ) and the discount department store category to: Dollar General, Family Dollar, and WalMart.
While there is a chance that these choices of categorization could miss establishments that sell tobacco or include establishments who did not, previous research has demonstrated the sensitivity and specificity of similarly using NAICS codes to identify tobacco retailers compared to in person visits to all tobacco retailers in three counties 1 and a high degree of concordance between measures of tobacco retailer density computed with purchased address lists and tobacco retailer licensing lists. The NETS data included information on street address, city, state, and longitude and latitude for every establishment. However, latitude and longitude values are truncated, which might lead to incorrect allocation when assigning retailers to a geographic unit as small as a census tracts. 3 Therefore, we first used the NETS truncated (four decimal place) latitude and longitude to identify retailers in the 500 cities sample, and then geocoded this subset of 120,470 addresses to census tracts. To geocode the subset of retailers within a study city, we used ArcGIS Version 10.4.1, supplemented by the Census Bureau online geocoder (https://geocoding.geo.census.gov/geocoder/) and Geocodido (https://geocod.io/upload/), and achieved a mapping rate was 98.9 %. The number of likely tobacco retailers was computed for each of the 27,204 census tracts with complete information (mean = 4.4 retailers, SD = 4.0).
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Description of Analytical Methods Used

Linear Mixed Models
We used linear mixed models to characterize smoking prevalence inequity within and between cities, assess tract level smoking prevalence as a function of tract level demographics and tobacco retailer counts, and assess tract level current asthma, COPD, and CHD prevalence as a function of tract level smoking prevalence. All models accounted for the clustering of census tracts within cities using a random effect for city. We characterized smoking prevalence inequity by using the variance decomposition from the random effects term in a null model with smoking prevalence entered as the outcome variable. We assessed the relationship between tract level smoking prevalence and tract level demographics and tobacco retailer counts in a multivariable model by setting tract level smoking prevalence as the outcome variable and simultaneously specifying fixed linear effects for tract level median household income (scaled to $10K increase), percent non Hispanic white population (scaled to 10 percentage point increase), the number of tobacco retailers (scaled to 5 store increase) and the total population size (Main Text; Table 1 ).
Listwise deletion was used for n=125 tracts that were missing information on household income. Similarly, we assessed the relationship between tract level prevalence of chronic diseases and smoking prevalence using multivariable models (Table S. 3). In these models the outcomes were the tract level prevalence of the chronic diseases of interest (asthma, COPD, CHD) and the predictor variable was tract level prevalence
smoking. For these model we simultaneously adjusted for tract level median household income, percent non Hispanic white population, and the total population size. We calculated the expected percent increase in prevalence of each chronic disease of changing from the 10 th to 90 th percentile of smoking prevalence
[(E(Y|X = 90 th percentile, Z) E(Y|X = 10 th percentile, Z))/ E(Y|X = 10 th percentile, Z); where Y = asthma, COPD or CHD prevalence, X = smoking prevalence and Z is a vector of covariate values] and the corresponding 95% confidence intervals using the multivariable linear mixed models and by using 1000 draws from the multivariate normal distribution with the mean equal to the maximum likelihood point estimate and the variance equal to the coefficient covariance matrix. 4 To calculate the expected percent increases, we set all covariates to their respective mean values. We used Gini coefficients to quantify smoking prevalence inequity in each city. 5, 6 Gini coefficients describe inequity by summarizing the dispersion of a quantitative measure. 7 The Gini coefficient is based on the Lorenz curve, which in our case plots the share of the cities' total average smoking prevalence that is cumulatively recorded by the bottom X% of the population. The Gini coefficient is the ratio of the area that lies between the line of equality and the Lorenz curve to the total area under the line of equality. The values of a Gini coefficient could range from 0 (complete equity) to 1 (complete inequity), since smoking prevalence cannot be negative.
Gini coefficients are the most popular measure for summarizing inequity, but other common measures include the coefficient of variation (COV) and Theil index. 8 To test the sensitivity of our results to the choice of inequity measure, we computed COV and Theil Index values for each city and compared them to © 2018 American Medical Association. All rights reserved.
the Gini coefficient values. The COV is the ratio of the standard deviation to the mean , It summarizes the extent of the variability in smoking prevalence between tracts in relation to the mean smoking prevalence across all tracts. Thus, higher values represent a greater relative difference between tracts. The Theil index is a measure of the entropic "distance" the population's smoking prevalence is away from the "ideal"
egalitarian state, where all tracts have the same smoking prevalence. The numeric result is in terms of negative entropy, where a higher values represent a population that is further away from complete equity.
Comparing the calculated values of both the COV and Theil index with the Gini coefficients at the city level, suggested that the choice of measure did not impact our conclusions of about the smoking prevalence inequity in the cities, as all measures were highly correlated (Pearson's r >0.98).
Map of smoking prevalence in Washington, DC
We created the map visualizing smoking prevalence in Washington, DC using ArcGIS Version 10.4. classes) based on the data for the Washington, DC census tracts. One Washington, DC census tract had insufficient data to make a smoking prevalence estimate and is illustrated in grey.
